TREATMENT OF RELAPSED WILMS TUMOUR (WT) PATIENTS: EXPERIENCE WITH TOPOTECAN

被引：0

作者：

Mavinkurve-Groothuis, A. M. C. ^{[1
]}

van den Heuvel-Eibrink, M. M. ^{[2
]}

Tytgat, G. A. ^{[3
]}

van Tinteren, H. ^{[4
]}

Vujanic, G. ^{[5
]}

Pritchard-Jones, K. ^{[6
]}

Howell, L. ^{[7
]}

Graf, N. ^{[8
]}

Bergeron, C. ^{[9
]}

Acha, T. ^{[10
]}

Spreafico, F. ^{[11
]}

机构：

[1] Radboudumc, Dept Pediat Hematol & Oncol, Nijmegen, Netherlands

[2] ErasmusMC Sophia Childrens Hosp, Dept Pediat Hematol & Oncol, Rotterdam, Netherlands

[3] Emma Childrens Hosp, Dept Pediat Oncol, Amsterdam, Netherlands

[4] Dutch Canc Inst NKI AvL, Dept Stat, Amsterdam, Netherlands

[5] Cardiff Univ, Sch Med, Dept Pathol, Cardiff CF10 3AX, S Glam, Wales

[6] UCL, Inst Child Hlth, London, England

[7] Alder Hey Childrens NHS Fdn Trust, Dept Pediat Oncol, Liverpool, Merseyside, England

[8] Univ Saarland, Homburg, Germany

[9] Inst Hematol & Oncol Pediat, Lyon, France

[10] Hosp Maternoinfantil, Dept Pediat Oncol, Malaga, Spain

[11] Fdn IRCCS Ist Nazl Tumori, Dept Hematol & Pediat Oncol, Pediat Oncol Unit, Milaan, Italy

来源：

PEDIATRIC BLOOD & CANCER | 2014年 / 61卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-262

引用

页码：S229 / S229

页数：1

共 50 条

[1] Treatment of Relapsed Wilms Tumour (WT) Patients: Experience With Topotecan. A Report From the SIOP Renal Tumour Study Group (RTSG)
Mavinkurve-Groothuis, A. M. C.
van den Heuvel-Eibrink, M. M.
Tytgat, G. A.
van Tinteren, H.
Vujanic, G.
Pritchard-Jones, K. L. P.
Howell, L.
Graf, N.
Bergeron, C.
Acha, T.
Catania, S.
Spreafico, F.
PEDIATRIC BLOOD & CANCER, 2015, 62 (04) : 598 - 602
[2] Optimizing Resources in Relapsed Wilms Tumour (WT) While Improving Outcomes
Prasad, M.
Srinivasan, S.
Panda, A.
Subramani, V.
Parambil, B.
Vora, T.
Ramadwar, M.
Khanna, N.
Laskar, S.
Baheti, A.
Smriti, V.
Qureshi, S.
Chinnaswamy, G.
PEDIATRIC BLOOD & CANCER, 2021, 68 : S236 - S236
[3] Outcome of Relapsed Wilms Tumour: A Single Center Experience
Schiavetti, A.
Pedetti, V.
Cozzi, D. A.
Celani, C.
Pellicori, F.
Marrucci, O.
Varrasso, G.
PEDIATRIC BLOOD & CANCER, 2016, 63 : S248 - S249
[4] TREATMENT AND OUTCOME OF PATIENTS WITH WILMS TUMOUR (WT) REGISTERED IN THE ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA (AIEOP)-WT-2003 PROTOCOL
Spreafico, F.
D'Angelo, P.
Di Cataldo, A.
Gandola, L.
Bianchi, M.
Indolfi, P.
Nantron, M.
Pession, A.
Perotti, D.
Provenzi, M.
Biasoni, D.
Morosi, C.
Terenziani, M.
Catania, S.
Collini, P.
PEDIATRIC BLOOD & CANCER, 2015, 62 : S176 - S176
[5] OUR EXPERIENCE WITH TOPOTECAN AS SECOND-LINE TREATMENT OF PATIENTS WITH RELAPSED SMALL CELL LUNG CANCER
Davidov, Deyan
JOURNAL OF IMAB, 2010, 16 (03): : 70 - 73
[6] Clinical experience with topotecan in relapsed ovarian cancer
Herzog, TJ
GYNECOLOGIC ONCOLOGY, 2003, 90 (03) : S3 - S7
[7] The wilms tumour gene WT1 in leukaemia
PritchardJones, K
KingUnderwood, L
LEUKEMIA & LYMPHOMA, 1997, 27 (3-4) : 207 - &
[8] BEVACIZUMAB FOR RELAPSED OR REFRACTORY WILMS TUMOUR - REVIEW OF THE LITERATURE
Al-Jilaihawi, Sarah
Spreafico, Filippo
Mavinkurve-Groothuis, Annelies
Drost, Jarno
Perotti, Daniela
Koenig, Chrisra
Brok, Jesper
PEDIATRIC BLOOD & CANCER, 2023, 70
[9] Vincristine, Irinotecan and Bevacizumab in Relapsed Anaplastic Wilms Tumour
Schiavetti, A.
Varrasso, G.
Collini, P.
Ferrara, E.
Paiano, M.
Clerico, A.
PEDIATRIC BLOOD & CANCER, 2016, 63 : S248 - S248
[10] Raised risk of Wilms tumour in patients with aniridia and submicroscopic WT1 deletion
van Heyningen, Veronica
Hoovers, Jan M. N.
de Kraker, Jan
Crolla, John A.
JOURNAL OF MEDICAL GENETICS, 2007, 44 (12) : 787 - 790

← 1 2 3 4 5 →